Agoracom Blog Home

Posts Tagged ‘#smallcaps’

Newer Entries »

INDUSTRY BULLETIN: IATA’s Positive Safety Trends Align with Star Navigation Systems’ Ascent

Posted by Aidi Munoz at 11:54 AM on Monday, November 13th, 2023

Industry Outlook and Star Navigation Systems’ Trajectory: The International Air Transport Association’s (IATA) recently released Safety Report for global aviation reflects a positive trend with reduced fatal accidents and a declining fatality risk. As the aviation industry looks towards enhanced safety, Star Navigation Systems stands as a beacon, strategically positioned to leverage and contribute to these advancements.

Voices of Authority: Willie Walsh, IATA’s Director General, emphasizes the significance of continued safety analysis despite aviation’s exceptional safety record. His insights align with Star Navigation Systems’ commitment to advancing aviation safety through cutting-edge technology.

Star Navigation Systems’ Highlights: 

  • Real time engine condition monitoring
  • Take off to landing aircraft, data analysis and fuel insights
  • One stop comprehensive data analysis dashboard
  • Automatic flight data transfer and end of flight reports to operator at end of each flight
  • Automatic black box data transfer from aircraft during distress

Star Navigation Systems is actively collaborating with key partners:

  • Aero Contractors: Advancing LOI with sales agents in Lagos, Nigeria, working to solidify a purchase order contract.
  • Air Peace: Received a proposal request from Nigeria’s Air Peace for Star-ISMS® installation across their fleet.
  • Astral Aviation: Announced the sale of seven aircraft in June 2022, with the project progressing, contributing to revenue streams.
  • Ethiopian Airlines: Submitted a comprehensive proposal to Ethiopian Airlines, covering data transmission, inflight analysis, post-flight tracking, and proactive maintenance capabilities.
  • Nigerian Air Force: Engaged in discussions to modernize the military with cutting-edge hardware and software solutions.
  • LOI with 30B PROJECT: LAPSSET African Infrastructure Project

STAR NAVIGATION HAS ANSWERED THE CALL

Real-world Relevance: In a world where every flight takes off and lands safely, Star Navigation Systems contributes by offering real-time inflight analysis and safety monitoring. Imagine a flight every day for 25,214 years to experience a 100% fatal accident—a testament to the industry’s low risk, made even safer by companies like Star Navigation Systems.

Looking Ahead with Star Navigation Systems: As the aviation industry embraces a risk-based safety model, Star Navigation Systems is at the forefront, aligning its goals with the industry’s commitment to continuous improvement. With a focus on global standards and innovations Star Navigation Systems is set to shape the future of connected aviation.

Conclusion: In the evolving landscape of aviation safety, Star Navigation Systems emerges as a pivotal player, contributing to the industry’s positive trajectory. Investors seeking a blend of technological innovation and industry foresight should closely watch Star Navigation Systems. The company’s commitment to safety aligns seamlessly with the industry’s upward trajectory, making it a compelling prospect for those keen on the future of aviation technology.

Tags: , , ,
Posted in Industry Bulletins, Star Navigation Systems (SNA: CSE), Star Navigation Systems (SNA:TSXV) | Comments Off on INDUSTRY BULLETIN: IATA’s Positive Safety Trends Align with Star Navigation Systems’ Ascent

EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY

Posted by Aidi Munoz at 9:40 AM on Tuesday, September 26th, 2023

Empower Clinics Inc (EPW: CSE) (EPWCF: PINK), a leading healthcare company, is proud to announce a significant milestone in its research and clinical trials division. Its subsidiary, EPW Curesearch LLC (“EPWC”), has successfully secured its inaugural clinical trial from a major European pharmaceutical powerhouse with a staggering market capitalization exceeding $100 billion. This monumental achievement is set to impact the future of healthcare outcomes worldwide.

Building upon its previous announcement on July 31, 2023, which highlighted multiple study applications covering diverse disease states, Empower Clinics confirms that this awarded clinical trial will be dedicated to addressing Chronic Obstructive Pulmonary Disease (COPD). The trial will be spearheaded by one of the company’s most seasoned Principal Investigators (PIs).

The collaboration between Empower Clinics, their PI, and the pharmaceutical sponsor is poised to enroll between 20 to 35 patients, primarily from the existing patient roster, with the recruitment window extending into mid-2024 and the possibility of extensions. Remarkably, there are no restrictions on the maximum number of patients per site, enabling EPWC to source additional participants from external medical centers, hospitals, and various social recruitment channels, including Facebook, Instagram, Twitter, and other digital marketing avenues.

Steven McAuley, Chairman & CEO of Empower Clinics, expressed his enthusiasm, stating, “We are all ecstatic to receive our first awarded clinical trial, a result of consistent and persistent effort over the past number of months. Our focus on partnering with large established medical centers and very experienced medical doctors has proven successful.” He further anticipates additional sponsor due diligence, site visits, and awards in the future.

Empower Clinics has strategically aligned itself with practicing medical doctors, who are specialists in their respective fields and have previous research and clinical trials experience. These PIs play a pivotal role in the success of Empower’s Site Management Organization (SMO), facilitating meaningful revenues from the Biotech and Pharmaceutical industries, providing oversight and support to patients, and acting as a crucial liaison between pharmaceutical companies and Contract Research Organizations (CROs).

While the company continues to navigate through a Cease Trade Order and accounting and audit procedures, the enormous market opportunity beckons. The Clinical Research Organization (CRO) Services Market is set to reach $127.3 billion by 2028, driven by the ever-expanding pharmaceutical, biotechnology, and medical device R&D pipelines, as well as advancements in clinical trial processes. Empower Clinics is positioned to play a pivotal role in this transformative era of healthcare.

About Empower:

Empower is a patient-focused healthcare company committed to making a positive impact on lives and future healthcare outcomes through clinical trials. With two clinical research sites and six principal investigators, Empower operates as a Site Management Organization (SMO) with multiple clinical trials in the pipeline. Additionally, the company has announced its intention to create a healthcare AI spinout focused on enhancing patient identification, recruitment, and onboarding for clinical trials.

Read release: https://www.einpresswire.com/article/657704521/empower-clinics-announces-award-of-first-clinical-trial-from-global-fortune-500-pharmaceutical-company

Tags: , ,
Posted in Empower Clinics Inc. | Comments Off on EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY

VIDEO – Delic Owns The Largest Profitable Chain Of Psychedelics Clinics In America – And Is Targeting Hundreds Of Locations Thanks To Patient Acceptance, Legislation And Insurance Support

Posted by Brittany McNabb at 5:51 PM on Thursday, October 20th, 2022

To understand Delic Holdings $DELC $DELCF you first must understand that Psychedelics are going to go through a parabolic, paradigm shifting growth cycle in the next 5 years because of their ability to treat anxiety, depression & other mental illnesses – which have proven to be far superior to traditional pharmaceuticals.  Just look at these numbers:

Response to Ketamine Treatment of Depressive Disorders:

• 80+ % Effective with Bipolar and Depression 

• 76+ % Effective with Major Depressive Disorders

• 65+ % Effective with Depression with PTSD and Anxiety 

• 50+ %  Effective with Borderline Personality Disorder

Compare these to 63% of Americans who have used Rx drugs to treat anxiety, depression and PTSD but say they still have symptoms. 

As incredible as these results are, both $DELC and Psychedelics couldn’t be coming along at a better time given the fact that Mental Health problems are getting exponentially worse after COVID, with 51.5M people in the U.S. having experienced a mental health condition

ENTER DELIC 

$DELC is the largest profitable chain of psychedelics clinics in the United States with 13 locations across 9 states – and 15 more locations coming in the next 18 months

How big is Delic?  The Company’s Ketamine Wellness Centers will serve more patients than any other ketamine therapy provider this year.  Other highlights include:

• $9m+ Revenue Run Rate & EBITDA Positive

• 2021 increase net assets to $10M+ from $2.1M in 2020

• Well capitalized to grow organically and via M&A as industry grows

GROWTH EXPECTED TO REACH HUNDREDS OF CLINICS

$DELC Co-Founder and Executive Chairman, Matt Stang isn’t resting on the Company’s leadership laurels and has set his sights on hundreds of clinics in the coming 5 years thanks to:

• Consumer Acceptance – The Public Is Fully Embracing Psychedelics

• Friendly Legislation –  Legalization Of MDMA & Psilocybin Treatments Is Coming

• Insurance Coverage – The Insurance Industry Is Increasingly Covering Psychedelics Treatments

To this end, Stang points to the Company’s most recent announcements as support for his growth target:

Ketamine Wellness Centers (KWC) Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

Ketamine Wellness Centers (KWC) Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO(TM) Coverage

If you believe in the future of psychedelics and want to know more about both the overall industry and Delic itself, then sit back and watch this great interview with Co-Founder and Executive Chairman, Matt Stang

YOUR NEXT $DELC STEPS

$DELC  HUB On AGORACOM: https://agoracom.com/ir/delicholdings

$DELC  5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/delicholdings/profile

$DELC  Official Verified Discussion Forum On AGORACOM:  https://agoracom.com/ir/delicholdings/forums/discussion

Connect With AGORACOM Anyway You Like

AGORACOM YouTube:  Hit That Subscribe Button Right Now For More Powerful Videos

AGORACOM Twitter:  https://www.twitter.com/AGORACOM Verified Top 0.2% Account

AGORACOM Spotify:  https://open.spotify.com/AGORACOM  Planes, Trains, Automobiles & Walking The Dog

AGORACOM Instagram: https://www.instagram.com/agoracomsmallcap/  Each Pic Is Worth 1,000 Words

AGORACOM Linkedin:   https://www.linkedin.com/company/agoracom For The Suits

AGORACOM Tik Tok:  https://www.tiktok.com/@agoracom We Don’t Dance … Promise

AGORACOM Facebook:  https://www.facebook.com/AGORACOM For The Moms and Dads

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Delic Holdings Corp | Comments Off on VIDEO – Delic Owns The Largest Profitable Chain Of Psychedelics Clinics In America – And Is Targeting Hundreds Of Locations Thanks To Patient Acceptance, Legislation And Insurance Support

Newer Entries »